DOCSLIB.ORG

Molecular Mechanisms of Congenital Hyperinsulinism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Molecular Mechanisms of Congenital Hyperinsulinism S A RAHMAN, A NESSA and others Congenital hyperinsulinism 54:2 R119–R129 Review Molecular mechanisms of congenital hyperinsulinism Sofia A Rahman1,*, Azizun Nessa1,* and Khalid Hussain1,2 Correspondence 1Genetics and Genomic Medicine, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK should be addressed 2Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS, 30 Guilford Street, to K Hussain London WC1N 1EH, UK Email *(S A Rahman and A Nessa contributed equally to this work) [email protected] Abstract Congenital hyperinsulinism (CHI) is a complex heterogeneous condition in which insulin Key Words secretion from pancreatic b-cells is unregulated and inappropriate for the level of blood " glucose glucose. The inappropriate insulin secretion drives glucose into the insulin-sensitive tissues, " insulin such as the muscle, liver and adipose tissue, leading to severe hyperinsulinaemic hypo- " congenital hyperinsulinism glycaemia (HH). At a molecular level, genetic abnormalities in nine different genes (ABCC8, " hypoglycaemia KCNJ11, GLUD1, GCK, HNF4A, HNF1A, SLC16A1, UCP2 and HADH) have been identified which " KATP channels cause CHI. Autosomal recessive and dominant mutations in ABCC8/KCNJ11 are the commonest " genetics cause of medically unresponsive CHI. Mutations in GLUD1 and HADH lead to leucine-induced " human HH, and these two genes encode the key enzymes glutamate dehydrogenase and short chain " development 3-hydroxyacyl-CoA dehydrogenase which play a key role in amino acid and fatty acid regulation of insulin secretion respectively. Genetic abnormalities in HNF4A and HNF1A lead to a dual phenotype of HH in the newborn period and maturity onset-diabetes later in life. Journal of Molecular This state of the art review provides an update on the molecular basis of CHI. Endocrinology Journal of Molecular Endocrinology (2015) 54, R119–R129 Introduction Congenital hyperinsulinism (CHI) refers to a group of The molecular basis of CHI involves defects in key disorders characterised by dysregulated insulin secretion genes that control the complex mechanisms of insulin from pancreatic b-cells. As insulin is the key hormone secretion in the pancreatic b-cell. Insulin secretion is involved in the regulation of the blood glucose level, its controlled to keep the fasting blood glucose level between inappropriate release leads to persistent hyperinsulinae- 3.5 and 5.5 mmol/l. Genetic mechanisms that perturb mic hypoglycaemia (HH). This drives glucose into the this precise control lead to HH. This review discusses the insulin sensitive tissues and simultaneously suppresses current knowledge of the molecular mechanisms that lead lipolysis and ketogenesis. The combined hypoketonaemic to unregulated insulin secretion. and hypoglycaemic characteristic of CHI increases the risk of brain injury in infants and children with this disorder Normal physiological mechanisms of insulin (Aynsley-Green et al. 2000). secretion CHI typically presents in the newborn period with symptoms of hypoglycaemia, with most cases being sporadic; Insulin secretion from pancreatic b-cells is primarily however, late-onset presentations of CHI can also occur. regulated by glucose metabolism. Post-prandial glucose The general CHI prevalence is 1:50 000 births increasing enters the b-cells via the non-insulin-dependent glucose to 1:2500 in consanguineous families (Bruining 1990). transporter type 2 (GLUT2). Glucose is then metabolised http://jme.endocrinology-journals.org Ñ 2015 Society for Endocrinology Published by Bioscientifica Ltd. DOI: 10.1530/JME-15-0016 Printed in Great Britain Downloaded from Bioscientifica.com at 09/23/2021 12:16:51PM via free access Review S A RAHMAN, A NESSA and others Congenital hyperinsulinism 54:2 R120 via glycolysis and tricarboxylic acid (TCA) cycles and Channelopathies yields the high-energy molecule, ATP. Pancreatic b-cells control insulin release by two major pathways; by means The ABCC8 gene: KATP–CHI The ABCC8 gene is of the ATP-sensitive potassium channels (KATP) and by found on chromosome 11p15.1, and contains 39 exons KATP-channel-independent means. (Inagaki et al.1995). This encodes the sulfonylurea The KATP-dependent control of insulin release is receptor 1 (SUR1) protein or an alternative spliced variant. dependent on changes in the ratio of ATP:ADP leading SUR1 is a member of the ATP-binding cassette trans- to closure of potassium channels and promotes membrane porters, which promote ATP hydrolysis to transport depolarisation. This triggers voltage-gated calcium substrates. However, SUR1 does not directly transport channels to open causing an influx of extracellular substrates, instead it regulates the activity of Kir6.2 in the calcium, which leads to exocytosis of insulin-containing KATP channel complex. A single SUR1 subunit is composed granules. On the other hand KATP-independent pathways of three transmembrane domains (TMD0, TMD1 and involves the augmentation of insulin secretion by increas- TMD2) containing 17 transmembrane helices, two cyto- C ing cytosolic Ca2 concentration and the recruitment of solic nucleotide-binding domains (NBD1 and NBD2) and a both b-cell protein kinases A and C to promote insulin cytosolic linker (L0) (Fig. 1). exocytosis (Gembal et al. 1992, Komatsu et al. 1995). In this review, we discuss the molecular mechanisms The KCNJ11 gene: KATP–CHI Like ABCC8,the of CHI that have given valuable insights into b-cell KCNJ11 gene is also located on chromosome 11p15.1, physiology and have aided in patient care and manage- containing a single exon. This encodes Kir6.2, a 390 amino ment. We outline the genetic basis of CHI and crucial acid protein (Inagaki et al. 1995). It is originally from a studies that have been pivotal in understanding this superfamily that is further divided into seven subfamilies complex and rare disease. ranging from Kir1 to Kir7. Kir6.2 is an unconventional pore-forming subunit of KATP channels which acts as a bio-diode in the cell surface. Kir proteins favour passing C Molecular genetics of CHI positive currents ‘inward’, even when the potassium (K ) concentration is equal on both sides of the membrane, So far, abnormalities in nine genes have been implicated and hence is termed an ‘inward rectifier’. Kir6.2 is a ‘weak’ in CHI; these are classified into two categories namely: inward rectifier unlike classic Kir channels (Doupnik et al. ‘channelopathies’ and ‘metabolopathies’ (Dunne et al. 1995). A single Kir6.2 subunit contains two putative 2004). The former is attributed to the KATP channel genes Journal of Molecular Endocrinology TMDs, linked by an extracellular pore-forming region (ABCC8 and KCNJ11) and latter to genes regulating and cytoplasmic -NH2 and -COOH terminal domains. different metabolic pathways (GLUD1, glucokinase (GCK), Within the K channel complex, the Kir6.2 subunit hepatocyte nuclear factor 4 homeobox A (HNF4A), HNF1A, ATP forms a tetrameric complex, harbouring the inhibitory SLC16A1,uncouplingprotein2(UCP2)andHADH) binding site (Saint-Martin et al. 2011). (Table 1). The most common disorders are those affecting the KATP channel genes and these are predominantly K –CHI Recessive inactivating mutations in the recessive mutations. The other seven genes are less ATP ABCC8 and KCNJ11 genes are the most common cause common causes of CHI, but are dominant mutations. of CHI. To date, 150 types of mutations in ABCC8 and 24 in KCNJ11 have been identified (Flanagan et al. Table 1 Incidence of CHI due to known genetic mutations 2009), these account for approximately 36.3% of all CHI cases (Kapoor et al. 2013). Mutations in ABCC8 or KCNJ11 Number of CHI cases Gene due to this gene (%) References can affect the functioning of KATP channels by either ABCC8/KCNJ11 36.3 Kapoor et al. (2013) affecting the surface expression or impairing the ability of GLUD1 5.9 Flanagan et al. (2010) MgADP to stimulate channel activity (Nichols et al. 1996). HADH 1 Kapoor et al. (2013) In either case, there is continuous depolarisation of the GCK !1 Glaser et al. (1998) b SLC16A1 !1 Otonkoski et al. (2003) pancreatic -cell membrane which leads to unregulated HNF4A 5 Flanagan et al. (2010) insulin secretion. HNF1A /1 Snider et al. (2013) Class 1 mutations in ABCC8 or KCNJ11 lead to UCP2 /1 Gonzalez-Barroso et al. (2008) proteins which fail to reach the plasma membrane due to the impaired synthesis or maturation of SUR1. http://jme.endocrinology-journals.org Ñ 2015 Society for Endocrinology Published by Bioscientifica Ltd. DOI: 10.1530/JME-15-0016 Printed in Great Britain Downloaded from Bioscientifica.com at 09/23/2021 12:16:51PM via free access Review S A RAHMAN, A NESSA and others Congenital hyperinsulinism 54:2 R121 A Sulfonylurea receptor type 1 (SUR1) Inward rectifier (Kir6.2) B pore-forming subunit Selectivity filter SUR1 NH2 Kir6.2 TMD0 TMD1 TMD2 M1 M2 Cell membrane 123 4 5 6 789 10 11 12 13 14 15 16 17 COOH Cytosol NBD2 CL3 Linker RKR RKR NH2 Walker A Walker B NBD1 Linker COOH Figure 1 Image of KATP channel structure in the cell membrane. (A) SUR1 is the putative membrane-spanning domains, which are linked by an extra- regulatory subunit composed of three TMDs (TMD0, TMD1 and TMD2), cellular pore-forming region and cytoplasmic -NH2 and -COOH terminal each with five to six transmembrane helices. There are two cytosolic domains. Both SUR1 and Kir6.2 contain the RKR sequence which is the nucleotide-binding domains (NBD1 and NBD2), and the conserved endoplasmic reticulum retention signal. (B) Illustration of the predicted sequences include the Walker A and Walker B motifs. The linker regions are octameric structure of KATP channels. It is made up of four Kir6.2 proteins in located between the Walker A and B motifs. Kir6.2 is the pore-forming the centre forming the pore, each with an associated SUR1 protein. subunit. It is a tetrameric complex made up of four proteins, each with two Alternatively, class 1 mutations can also lead to defective and enables the protein complex to exit the ER.
Load more

Recommended publications
  • Studies of Streptozotocin-Induced Insulitis and Diabetes
    Proc. NatI. Acad. Sci. USA Vol. 74, No. 6, pp. 2485-2489, June 1977 "I ", .4-4" I- Cell Biology ,- -i,' Studies of streptozotocin-induced insulitis and diabetes (pancreatic beta cells/islets of Langerhans/alloxan diabetes/type C virus induction/cell-mediated reaction) ALDO A. ROSSINI*, ARTHUR A. LIKEt, WILLIAM L. CHICK*, MICHAEL C. APPELt, AND GEORGE F. CAHILL, JR. * * Joslin Research Laboratory, One Joslin Place, Boston, Massachusetts 02215 and Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02215; and t Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01605 Communicated by Eugene Braunwald, April 4, 1977 ABSTRACT Multiple small injections of streptozotocin was a subsequent decrease in inflammation within the re- produce a delayed, progressive increase in plasma-glucose in maining islets which were small and composed almost exclu- mice within 5-6 days after the injections, in association with sively of non-beta cells. Blood glucose values remained in the pronounced insulitis and induction of type C viruses within beta cells. Multiple subdiabetogenic doses of streptozotocin in rats diabetic range and correlated well with the pathologic changes and multiple injections of another beta cell toxin, alloxan, in within the islets. Noteworthy also was the presence of numerous mice did not induce insulitis although hyperglycemia followed type C viruses within the surviving beta cells of animals studied the injection of larger quantities of both agents. In mice, the within 6 days of the last SZ injection. The delayed development prior injection of 3-O-methyl-D-glucose (3-OMG) or nicotin- of the insulitis and the nature of the inflammatory infiltrate amide attenuated the diabetic syndrome produced by strepto- zotocin; however, 3-OMG was more protective.
    [Show full text]
  • Multiple Low-Dose Streptozotocin-Induced Diabetes in the Mouse
    Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. R C McEvoy, … , S Sandler, C Hellerström J Clin Invest. 1984;74(3):715-722. https://doi.org/10.1172/JCI111487. Research Article Mice were examined for the presence of splenocytes specifically cytotoxic for a rat insulinoma cell line (RIN) during the induction of diabetes by streptozotocin (SZ) in multiple low doses (Multi-Strep). Cytotoxicity was quantitated by the release of 51Cr from damaged cells. A low but statistically significant level of cytolysis (5%) by splenocytes was first detectable on day 8 after the first dose of SZ. The cytotoxicity reached a maximum of approximately 9% on day 10 and slowly decreased thereafter, becoming undetectable 42 d after SZ was first given. The time course of the in vitro cytotoxic response correlated with the degree of insulitis demonstrable in the pancreata of the Multi-Strep mice. The degree of cytotoxicity after Multi-Strep was related to the number of effector splenocytes to which the target RIN cells were exposed and was comparable to that detectable after immunization by intraperitoneal injection of RIN cells in normal mice. The cytotoxicity was specific for insulin-producing cells; syngeneic, allogeneic, and xenogeneic lymphocytes and lymphoblasts, 3T3 cells, and a human keratinocyte cell line were not specifically lysed by the splenocytes of the Multi- Strep mice. This phenomenon was limited to the Multi-Strep mice. Splenocytes from mice made diabetic by a single, high dose of SZ exhibited a very low level of cytotoxicity against the RIN cells.
    [Show full text]
  • Hyperinsulinemic Hypoglycemia in Infancy: Current Concepts in Diagnosis and Management
    RRR EEE VVV III EEE WWW AAA RRR TTT III CCC LLL EEE Hyperinsulinemic Hypoglycemia in Infancy: Current Concepts in Diagnosis and Management SHRENIK VORA, SURESH CHANDRAN, VICTOR SAMUEL RAJADURAI AND #KHALID HUSSAIN From Department of Neonatology, KK Women’s and Children’s Hospital, Singapore; and #Genetics and Epigenetics in Health and Disease Genetics and Genomic Medicine Programme, UCL Institute of Child Health, Great Ormond Street Hospital for Children, 30 Guilford Street, London, UK. Correspondence to: Dr Shrenik Vora, Senior Staff Registrar, Department of Neonatology, KK Women’s and Children’s Hospital, 100, Bukit Timah Road, Singapore 229899. [email protected] Purpose: Molecular basis of various forms of hyperinsulinemic hypoglycemia, involving defects in key genes regulating insulin secretion, are being increasingly reported. However, the management of medically unresponsive hyperinsulinism still remains a challenge as current facilities for genetic diagnosis and appropriate imaging are limited only to very few centers in the world. We aim to provide an overview of spectrum of clinical presentation, diagnosis and management of hyperinsulinism. Methods: We searched the Cochrane library, MEDLINE and EMBASE databases, and reference lists of identified studies. Conclusions: Analysis of blood samples, collected at the time of hypoglycemic episodes, for intermediary metabolites and hormones is critical for diagnosis and treatment. Increased awareness among clinicians about infants “at-risk” of hypoglycemia, and recent advances in genetic diagnosis have made remarkable contribution to the diagnosis and management of hyperinsulinism. Newer drugs like lanreotide (long acting somatostatin analogue) and sirolimus (mammalian target of rapamycin (mTOR) inhibitor) appears promising as patients with diffuse disease can be treated successfully without subtotal pancreatectomy, minimizing the long-term sequelae of diabetes and pancreatic insufficiency.
    [Show full text]
  • Mechanisms of Disease: Advances in Diagnosis and Treatment of Hyperinsulinism in Neonates Diva D De León and Charles a Stanley*
    REVIEW www.nature.com/clinicalpractice/endmet Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates Diva D De León and Charles A Stanley* SUMMARY INTRODUCTION Etiology of neonatal hypoglycemia Hyperinsulinism is the single most common mechanism of hypoglycemia Hypoglycemia is a frequent problem in newborn in neonates. Dysregulated insulin secretion is responsible for the infants that must be diagnosed and treated effi- transient and prolonged forms of neonatal hypoglycemia, and congenital ciently to avoid seizures and permanent brain genetic disorders of insulin regulation represent the most common damage. Management is complicated by the fact of the permanent disorders of hypoglycemia. Mutations in at least five genes have been associated with congenital hyperinsulinism: they that neonates present a remarkably wide range of encode glucokinase, glutamate dehydrogenase, the mitochondrial possible causes for hypoglycemia. These include enzyme short-chain 3-hydroxyacyl-CoA dehydrogenase, and the two transient forms of hypoglycemia that can occur components (sulfonylurea receptor 1 and potassium inward rectifying in normal infants, more prolonged forms of channel, subfamily J, member 11) of the ATP-sensitive potassium hypoglycemia that are associated with compli- channels (K channels). K hyperinsulinism is the most common and cations of gestation and delivery, and neonatal ATP ATP presentation of permanent hypo glycemia severe form of congenital hyperinsulinism. Infants suffering from KATP hyperinsulinism present shortly after birth with severe and persistent dis orders due to endocrine or metabolic diseases hypoglycemia, and the majority are unresponsive to medical therapy, thus (Box 1). The risks of these various forms change requiring pancreatectomy. In up to 40–60% of the children with KATP hyperinsulinism, the defect is limited to a focal lesion in the pancreas.
    [Show full text]
  • Hypoglycemia Diagnosis and Management
    HYPOGLYCEMIA DIAGNOSIS AND MANAGEMENT Beckwith-Wiedemann syndrome (BWS) is a rare disorder involving changes on a region of chromosome 11p15 that influence pre- and postnatal growth. These changes disrupt the normal balance of growth gene expression and lead to the overgrowth seen in patients with BWS. Depending on which parts of the body are affected, children with BWS can have different features. These include overgrowth of the pancreas leading to hypoglycemia or hyperinsulinism. What is hypoglycemia? Hypoglycemia is low blood sugar. It is important for the body to have normal blood sugar levels because low sugar levels can cause problems including seizures and brain damage. Approximately half of infants with BWS will have hypoglycemia. In most of these children, hypoglycemia will only last for a few days and can easily be treated with frequent feedings and/or medical doses of sugar (dextrose infusions). However, in 5-10% of children with BWS, hypoglycemia can persist, requiring additional monitoring and medical care. What causes hypoglycemia in children with BWS? Although hypoglycemia can happen for many reasons, in children with BWS, it is usually caused when the pancreas makes too much insulin (hyperinsulinism). Insulin lowers blood sugar (also called glucose) levels. We suspect that low blood sugar levels in BWS have to do with the genes on chromosome 11p15 that control growth. Additionally, there are some other genes on chromosome 11 that affect how some of the cells in the pancreas work. How do we test for hypoglycemia? A normal blood sugar level is 70 – 120 mg/dL. Low glucose levels are common in the first 24 hours of life; after the second day of life, glucose levels should normalize.
    [Show full text]
  • Residual Β Cell Function and Monogenic Variants in Long- Duration Type 1 Diabetes Patients
    Residual β cell function and monogenic variants in long- duration type 1 diabetes patients Marc Gregory Yu, … , Marcus G. Pezzolesi, George Liang King J Clin Invest. 2019. https://doi.org/10.1172/JCI127397. Clinical Medicine Endocrinology Metabolism In the Joslin Medalist Study (Medalists), we determined whether significant associations exist between β cell function and pathology and clinical characteristics. Individuals with type 1 diabetes (T1D) for 50 or more years underwent evaluation including HLA analysis, basal and longitudinal autoantibody (AAb) status, and β cell function by a mixed-meal tolerance test (MMTT) and a hyperglycemia/arginine clamp procedure. Postmortem analysis of pancreases from 68 Medalists was performed. Monogenic diabetes genes were screened for the entire cohort. Of the 1019 Medalists, 32.4% retained detectable C-peptide levels (>0.05 ng/mL, median: 0.21 ng/mL). In those who underwent a MMTT (n = 516), 5.8% responded with a doubling of baseline C-peptide levels. Longitudinally n( = 181, median: 4 years), C-peptide levels increased in 12.2% (n = 22) and decreased in 37% (n = 67) of the Medalists. Among those with repeated MMTTs, 5.4% (3 of 56) and 16.1% (9 of 56) had waxing and waning responses, respectively. Thirty Medalists with baseline C-peptide levels of 0.1 ng/mL or higher underwent the clamp procedure, with HLA–/AAb– and HLA+/AAb– Medalists being most responsive. Postmortem examination of pancreases from 68 Medalists showed that all had scattered insulin-positive […] Find the latest version: https://jci.me/127397/pdf The Journal of Clinical Investigation CLINICAL MEDICINE Residual β cell function and monogenic variants in long-duration type 1 diabetes patients Marc Gregory Yu,1,2 Hillary A.
    [Show full text]
  • Impaired Hormonal Responses to Hypoglycemia in Spontaneously Diabetic and Recurrently Hypoglycemic Rats
    Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits. A M Powell, … , R S Sherwin, G I Shulman J Clin Invest. 1993;92(6):2667-2674. https://doi.org/10.1172/JCI116883. Research Article To evaluate the roles of iatrogenic hypoglycemia and diabetes per se in the pathogenesis of defective hormonal counterregulation against hypoglycemia in insulin-dependent diabetes mellitus (IDDM), nondiabetic, and spontaneously diabetic BB/Wor rats were studied using a euglycemic/hypoglycemic clamp. In nondiabetic rats, recurrent (4 wk) insulin- induced hypoglycemia (mean daily glucose, MDG, 59 mg/dl) dramatically reduced glucagon and epinephrine responses by 84 and 94%, respectively, to a standardized glucose fall from 110 to 50 mg/dl. These deficits persisted for > 4 d after restoring normoglycemia, and were specific for hypoglycemia, with normal glucagon and epinephrine responses to arginine and hypovolemia, respectively. After 4 wk of normoglycemia, hormonal counterregulation increased, with the epinephrine, but not the glucagon response reaching control values. In diabetic BB rats (MDG 245 mg/dl with intermittent hypoglycemia), glucagon and epinephrine counterregulation were reduced by 86 and 90%, respectively. Chronic iatrogenic hypoglycemia (MDG 52 mg/dl) further suppressed counterregulation. Prospective elimination of hypoglycemia (MDG 432 mg/dl) improved, but did not normalize hormonal counterregulation. In diabetic rats, the glucagon defect appeared to be specific for hypoglycemia, whereas deficient epinephrine secretion also occurred during hypovolemia. We concluded that both recurrent hypoglycemia and the diabetic state independently lead to defective hormonal counterregulation. These data suggest that in IDDM iatrogenic hypoglycemia magnifies preexisting counterregulatory defects, thereby increasing the risk of severe hypoglycemia.
    [Show full text]
  • Congenital Hyperinsulinism
    Winner of the Case of the Year SWISS SOCIETY OF NEONATOLOGY Award 2012 Congenital hyperinsulinism FEBRUARY 2012 2 Morgillo D, Berger TM, Caduff JH, Barthlen W, Mohnike K, Mohnike W, Neonatal and Pediatric Intensive Care Unit (MD, BTM), Department of Pediatric Radiology (CJH), Children‘s Hospital of Lucerne, Lucerne, Switzerland, Department of Pediatric Surgery, University Medicine Greifswald (BW), Greifswald, Germany, Department of Pediatrics, University Hospital of Magdeburg (MK), Magdeburg, Germany, Diagnostic Therapeutic Centre Frankfurter Tor (MW), Berlin, Germany © Swiss Society of Neonatology, Thomas M Berger, Webmaster 3 Congenital hyperinsulinism (CHI) is characterized by INTRODUCTION inappropriate secretion of insulin by the ß cells of the islets of Langerhans and is an extremely heterogene- ous condition in terms of clinical presentation, histo- logical subgroups and underlying molecular biology. Histologically, CHI has been classified into two major subgroups: diffuse (affecting the whole pancreas) and focal (being localized to a single region of the pancreas) disease. Advances in molecular genetics, radiological imaging techniques (such as fluorine-18 L-3,4-dihydroxyphenylalanine-PET-CT (18FDOPA-PET-CT) scanning) and surgical techniques have completely changed the clinical approach to infants with severe congenital forms of hyperinsulinemic hypoglycemia. This male infant was born to a healthy 35-year-old G3/P3 CASE REPORT by spontaneous vaginal delivery at 38 4/7 weeks. His birth weight was 3530 g (P 50-75), his head circum- ference was 35 cm (P 25) and his length was 50 cm (P 25-50). Postnatal adaptation was normal with an arterial cord pH of 7.28 and Apgar scores of 8, 9, and 9 at 1, 5, and 10 minutes, respectively.
    [Show full text]
  • Gut Microbiota Differs in Composition and Functionality Between Children
    Diabetes Care Volume 41, November 2018 2385 Gut Microbiota Differs in Isabel Leiva-Gea,1 Lidia Sanchez-Alcoholado,´ 2 Composition and Functionality Beatriz Mart´ın-Tejedor,1 Daniel Castellano-Castillo,2,3 Between Children With Type 1 Isabel Moreno-Indias,2,3 Antonio Urda-Cardona,1 Diabetes and MODY2 and Healthy Francisco J. Tinahones,2,3 Jose´ Carlos Fernandez-Garc´ ´ıa,2,3 and Control Subjects: A Case-Control Mar´ıa Isabel Queipo-Ortuno~ 2,3 Study Diabetes Care 2018;41:2385–2395 | https://doi.org/10.2337/dc18-0253 OBJECTIVE Type 1 diabetes is associated with compositional differences in gut microbiota. To date, no microbiome studies have been performed in maturity-onset diabetes of the young 2 (MODY2), a monogenic cause of diabetes. Gut microbiota of type 1 diabetes, MODY2, and healthy control subjects was compared. PATHOPHYSIOLOGY/COMPLICATIONS RESEARCH DESIGN AND METHODS This was a case-control study in 15 children with type 1 diabetes, 15 children with MODY2, and 13 healthy children. Metabolic control and potential factors mod- ifying gut microbiota were controlled. Microbiome composition was determined by 16S rRNA pyrosequencing. 1Pediatric Endocrinology, Hospital Materno- Infantil, Malaga,´ Spain RESULTS 2Clinical Management Unit of Endocrinology and Compared with healthy control subjects, type 1 diabetes was associated with a Nutrition, Laboratory of the Biomedical Research significantly lower microbiota diversity, a significantly higher relative abundance of Institute of Malaga,´ Virgen de la Victoria Uni- Bacteroides Ruminococcus Veillonella Blautia Streptococcus versityHospital,Universidad de Malaga,M´ alaga,´ , , , , and genera, and a Spain lower relative abundance of Bifidobacterium, Roseburia, Faecalibacterium, and 3Centro de Investigacion´ BiomedicaenRed(CIBER)´ Lachnospira.
    [Show full text]
  • Functional Imaging of Insulitis in Type 1 Diabetes
    FUNCTIONAL IMAGING OF INSULITIS IN TYPE 1 DIABETES Teemu Kalliokoski TURUN YLIOPISTON JULKAISUJA – ANNALES UNIVERSITATIS TURKUENSIS Sarja - ser. D osa - tom. 1135 | Medica - Odontologica | Turku 2014 University of Turku Faculty of Medicine Department of Clinical Medicine Pediatrics and Turku PET Centre Doctoral Programme of Clinical Investigation Supervised by Professor emeritus Olli Simell (MD, PhD) Adjunct professor Merja Haaparanta-Solin (MSc, PhD) University of Turku, Faculty of Medicine University of Turku, Faculty of Medicine Department of Pediatrics Turku PET Centre Reviewed by Professor Timo Otonkoski (MD, PhD) Docent Olof Eriksson (MSc, PhD) University of Helsinki Uppsala University Children’s Hospital Department of Medicinal Chemistry Opponent Professor Alberto Signore (MD, PhD) Sapienza University Nuclear Medicine Unit Rome, Italy The originality of this thesis has been checked in accordance with the University of Turku quality assurance system using the Turnitin OriginalityCheck service. ISBN 978-951-29-5859-7 (PRINT) ISBN 978-951-29-5860-3 (PDF) ISSN 0355-9483 Painosalama Oy - Turku, Finland 2014 Adjunct professor Merja Haaparanta-Solin (MSc, PhD) University of Turku, Faculty of Medicine Turku PET Centre To Mervi, and our children Elias and Iiris 4 Abstract ABSTRACT Teemu Kalliokoski FUNCTIONAL IMAGING OF INSULITIS IN TYPE 1 DIABETES Department of Pediatrics and Turku PET Centre, Faculty of Medicine, University of Turku Annales Universitatis Turkuensis, 2014, Turku, Finland Type 1 diabetes (T1D) is an immune-mediated disease characterized by autoimmune inflammation (insulitis), leading to destruction of insulin-producing pancreatic β-cells and consequent dependence on exogenous insulin. Current evidence suggests that T1D arises in genetically susceptible children who are exposed to poorly characterized environmental triggers.
    [Show full text]
  • Insulitis and Diabetes: a Perspective on Islet Inflammation
    ome Re un se m a rc Im h Immunome Research Burke and Collier, Immunome Res 2014, S:2 ISSN: 1745-7580 DOI: 10.4172/1745-7580.S2.e002 Editorial Open Access Insulitis and Diabetes: A Perspective on Islet Inflammation Susan J Burke and J Jason Collier* Laboratory of Islet Biology and Inflammation Pennington Biomedical Research Center 6400 Perkins Rd., Baton Rouge, LA 70808, USA *Corresponding author: J. Jason Collier, Ph.D, Laboratory of Islet Biology and Inflammation, Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808, USA, Tel: (225) 763-2884; E-mail: [email protected] Received date: 8 April 2014; Accepted date: 12 May 2014; Published date: 30 May 2014 Copyright: © Collier JJ et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract capable of secreting moderate to high amounts of inflammatory mediators, perhaps producing a more sudden onset of diabetes. This Immune cell infiltration into pancreatic islets (termed insulitis) has scenario may explain the reported cases of fulminant diabetes, where been linked with destruction of pancreatic β-cells and thus with onset destruction of β-cells and ensuing diabetes is rapid [5]. of diabetes mellitus. Recently published guidelines for reporting insulitis may generate some deliberation on pancreatic islet Small Quantitative Insulitis with moderate inflammatory Activity: inflammation and a re-examination of the role that immune cells play Fewer leukocytes with sustained, but moderate production of in the process of β-cell death and dysfunction.
    [Show full text]
  • Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
    molecules Review Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes Alina Kuryłowicz * and Krzysztof Ko´zniewski Department of Human Epigenetics, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-226-086-591; Fax: +48-226-086-410 Academic Editor: Masahide Hamaguchi Received: 31 March 2020; Accepted: 2 May 2020; Published: 9 May 2020 Abstract: One of the concepts explaining the coincidence of obesity and type 2 diabetes (T2D) is the metaflammation theory. This chronic, low-grade inflammatory state originating from metabolic cells in response to excess nutrients, contributes to the development of T2D by increasing insulin resistance in peripheral tissues (mainly in the liver, muscles, and adipose tissue) and by targeting pancreatic islets and in this way impairing insulin secretion. Given the role of this not related to infection inflammation in the development of both: insulin resistance and insulitis, anti-inflammatory strategies could be helpful not only to control T2D symptoms but also to treat its causes. This review presents current concepts regarding the role of metaflammation in the development of T2D in obese individuals as well as data concerning possible application of different anti-inflammatory strategies (including lifestyle interventions, the extra-glycemic potential of classical antidiabetic compounds, nonsteroidal anti-inflammatory drugs, immunomodulatory therapies, and bariatric surgery) in the management of T2D. Keywords: metaflammation; insulin resistance; insulitis; type 2 diabetes; anti-inflammatory treatment 1. Introduction A sedentary lifestyle combined with increased consumption of more energy-dense food results in a situation when obesity has reached epidemic proportions globally.
    [Show full text]